TR200401572T4 - Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim - Google Patents

Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim

Info

Publication number
TR200401572T4
TR200401572T4 TR2004/01572T TR200401572T TR200401572T4 TR 200401572 T4 TR200401572 T4 TR 200401572T4 TR 2004/01572 T TR2004/01572 T TR 2004/01572T TR 200401572 T TR200401572 T TR 200401572T TR 200401572 T4 TR200401572 T4 TR 200401572T4
Authority
TR
Turkey
Prior art keywords
disorders
prevention
treatment
composition
metabolism
Prior art date
Application number
TR2004/01572T
Other languages
English (en)
Inventor
Pola Pietro
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of TR200401572T4 publication Critical patent/TR200401572T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Lipid metabolizmasi bozukluklari ve alerjik formlarin önlenmesi ve/veya tedavisi için ve enfeksiyonlar ve tümör proseslerine karsi organik savunmalarina aktive edilmesi için, saglik yiyecek/diyet takviyesi olarak ya da bir ilaç olarak kullanilabilen, kendisini karakterize eden izovaleril L-karnitin ve glukanlar ve galaktanlar arasinda seçilen bir polisakkaridi kapsayan bir bilesim açiklanmaktadir.
TR2004/01572T 2000-11-17 2001-07-24 Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim TR200401572T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000602A IT1317938B1 (it) 2000-11-17 2000-11-17 Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese

Publications (1)

Publication Number Publication Date
TR200401572T4 true TR200401572T4 (tr) 2004-09-21

Family

ID=11455002

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01572T TR200401572T4 (tr) 2000-11-17 2001-07-24 Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim

Country Status (19)

Country Link
US (1) US7211571B2 (tr)
EP (1) EP1257267B1 (tr)
AT (1) ATE269073T1 (tr)
AU (1) AU778952B2 (tr)
CA (1) CA2406925A1 (tr)
CZ (1) CZ20022307A3 (tr)
DE (1) DE60103854T2 (tr)
DK (1) DK1257267T3 (tr)
ES (1) ES2222388T3 (tr)
HU (1) HUP0204209A3 (tr)
IL (1) IL150637A0 (tr)
IT (1) IT1317938B1 (tr)
MX (1) MXPA02007001A (tr)
NO (1) NO20023117L (tr)
PL (1) PL355200A1 (tr)
PT (1) PT1257267E (tr)
SK (1) SK10282002A3 (tr)
TR (1) TR200401572T4 (tr)
WO (1) WO2002040012A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
EA201101519A1 (ru) 2009-05-11 2012-10-30 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Способы диагностики метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
BR112015025424A2 (pt) 2013-04-08 2017-07-18 Berg Llc tratamento de câncer usando terapias de combinação de coenzima q10
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975421A (en) * 1985-08-19 1990-12-04 Bioglucan, Lp. Soluble phosphorylated glucan: methods and compositions for wound healing
US5977073A (en) * 1991-06-06 1999-11-02 Life Sciences' Technologies, Inc. Nutrient composition for treatment of immune disorders
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
JP2003517018A (ja) 1999-12-16 2003-05-20 シスキンド，ハリー 栄養組成物、該組成物を製造する方法、及び該組成物を使用する方法

Also Published As

Publication number Publication date
AU778952B2 (en) 2004-12-23
HUP0204209A2 (hu) 2003-04-28
MXPA02007001A (es) 2003-01-28
AU7667501A (en) 2002-05-27
ITRM20000602A0 (it) 2000-11-17
EP1257267B1 (en) 2004-06-16
HUP0204209A3 (en) 2005-03-29
ATE269073T1 (de) 2004-07-15
ES2222388T3 (es) 2005-02-01
IT1317938B1 (it) 2003-07-15
SK10282002A3 (sk) 2003-03-04
DE60103854T2 (de) 2005-07-14
US7211571B2 (en) 2007-05-01
EP1257267A1 (en) 2002-11-20
US20030017999A1 (en) 2003-01-23
ITRM20000602A1 (it) 2002-05-17
NO20023117D0 (no) 2002-06-27
CA2406925A1 (en) 2002-05-23
DE60103854D1 (de) 2004-07-22
CZ20022307A3 (cs) 2003-01-15
NO20023117L (no) 2002-06-27
DK1257267T3 (da) 2004-10-25
IL150637A0 (en) 2003-02-12
PT1257267E (pt) 2004-09-30
WO2002040012A1 (en) 2002-05-23
PL355200A1 (en) 2004-04-05

Similar Documents

Publication Publication Date Title
WO2000011968A8 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
WO2006017692A3 (en) Novel fenofibrate formulations and related methods of treatment
WO2006002909A3 (en) Sphingolipids against pathological processes in lipid rafts
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2007089703A3 (en) Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
AR064332A1 (es) Composicion suplementaria nutricional o dietetica que fortalece y promueve la salud retinal
WO2007075923A3 (en) Treatment of synucleinopathies
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
UA88165C2 (en) Use of trisubstituted benzopyranones
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
EP2322536A3 (en) Aminothiazole derivatives and their uses as antibacterial agents
EP2060914A3 (en) Nutritional compositions for modulating vitamin C bio-availability
TR200401572T4 (tr) Lipid-Metabolizması bozuklukları-alerjik formların önlenmesi ve/veya tedavisi için bileşim
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
WO2008080682A3 (de) Synergistische kombination von seidenproteinen und ausgewählten metallen
ATE424120T1 (de) Betainhaltige nahrung gegen muskelschwund
WO2007045639A8 (en) Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
WO2006120360A3 (fr) Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.
ATE367742T1 (de) Nahrungsergänzungspräparat enthaltend alpha- liponsäure und anthocyanoside